by
Gus Iversen, Editor in Chief | October 03, 2025
Royal Philips unveiled a suite of new imaging systems at the annual ASTRO meeting designed to improve precision and workflow in radiation therapy.
The Netherlands-based imaging OEM introduced two new CT platforms, Rembra RT and Areta RT, as well as an updated version of its helium-free BlueSeal RT 1.5T MR scanner.
The Rembra RT and Areta RT systems are built for CT simulation in radiation oncology, offering faster image reconstruction — up to 106 images per second — and a wide 85 cm bore. Both platforms incorporate next-generation 4DCT imaging that supports full respiratory cycle scans, and allow for breath rates ranging from 4 to 40 breaths per minute.
Ad Statistics
Times Displayed: 344592
Times Visited: 21056 MIT labs, experts in Multi-Vendor component level repair of: MRI Coils, RF amplifiers, Gradient Amplifiers Contrast Media Injectors. System repairs, sub-assembly repairs, component level repairs, refurbish/calibrate. info@mitlabsusa.com/+1 (305) 470-8013
According to Dan Xu, business leader of CT at Philips, “With Rembra RT and Areta RT, we’re once again setting new standards in radiation therapy, empowering care teams with the precision, dependability, and speed they need to deliver the best outcomes for patients.”
The CT systems also include remote collaboration features for training and planning, a shared-use radiology mode, and are covered by Philips’ “Tube for Life” guarantee, which includes long-term serviceability under certain conditions. Additionally, Philips is exploring integration with MVision AI’s Contour+ software, which offers auto-segmentation capabilities to assist in delineating organs at risk and lymph nodes.
On the MR side, Philips introduced the BlueSeal RT, a 1.5T 70 cm bore scanner specifically developed for radiation oncology departments. The system features SmartSpeed Precise, an AI-powered acceleration platform, and supports MR-only simulation protocols that can be completed in as little as 10 minutes.
BlueSeal RT continues Philips’ focus on helium-free MR, with approximately 2,000 such systems installed globally. The design eliminates the need for vent pipes and uses PowerSave+ technology to reduce energy consumption, expanding installation flexibility for sites with infrastructure limitations.
“By combining helium-free sustainability with AI-powered acceleration, we’re enabling radiation oncology teams to plan and simulate with greater speed, accuracy, and confidence, while enhancing the patient experience,” said Ioannis Panagiotelis, Ph.D., business leader, MR at Philips.
